Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
11:10am, Tuesday, 11'th Jun 2024
Data from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination vaccine generates higher immune responses when compared to co-administered licensed flu and COVID v
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Moderna, Inc. ("Moderna" or "the Company") (NASDAQ:MRNA). In
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
06:00am, Tuesday, 11'th Jun 2024
On Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part of the 2024-2025 campaign against new Covid strains. Drug manufacturers have been waiting on appro
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
06:56pm, Monday, 10'th Jun 2024
In the latest trading session, Moderna (MRNA) closed at $148.59, marking a -1.6% move from the previous day.
3 Biotech Stocks to Monitor Right Now
03:33pm, Monday, 10'th Jun 2024
Last week, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month.
NEW YORK, NY / ACCESSWIRE / June 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Moderna, Inc. ("Moderna" or "the Company") (NASDAQ:MRNA). In
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
10:40am, Monday, 10'th Jun 2024
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
Moderna CEO on side effects of combination vaccine
10:17am, Monday, 10'th Jun 2024
“We think it's a very good tradeoff for consumers and doctors,” Moderna CEO Stephane Bancel said on the side effects of the company's combination vaccine that targets both Covid-19 and the flu.
NEW YORK--(BUSINESS WIRE)---- $MRNA #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Moderna, Inc. (“Moderna” or
Moderna's combination flu & Covid vaccine is more effective than existing shots in late-stage trial
08:12am, Monday, 10'th Jun 2024
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss the data from its phase three trial of a combination flu and Covid-19 vaccine, the company's vaccine pipeline outlook, and more.
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial Finds
07:09am, Monday, 10'th Jun 2024
Moderna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response against both viruses than licensed vaccines on the market, promising findings for the mRNA company as it
Moderna COVID/flu combo vaccine superior to separate shots in trial
06:36am, Monday, 10'th Jun 2024
Moderna said on Monday its combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots against th
Moderna's combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
06:32am, Monday, 10'th Jun 2024
Moderna Inc.'s MRNA, -2.38% experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the compan
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
06:30am, Monday, 10'th Jun 2024
Moderna said Monday its Covid/flu vaccine topped rivals from GSK and Sanofi, and its own Spikevax shot. Moderna stock has risen this year.
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
06:30am, Monday, 10'th Jun 2024
Moderna said its combination vaccine targeting Covid and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. The biotech company is the first to releas
